NHS ten-year plan should result in faster medicines access, says NICE Under the ten-year health plan, the National Institute for Health and Care Excellence and Medicines and Healthcare products Regulatory Agency will work together to speed up medicines approvals.…
NICE recommends weekly injection for severe haemophilia B The National Institute for Health and Care Excellence said that marstacimab is a cost-effective treatment option for severe haemophilia B but not for severe haemophilia A.…
Pharmacy bodies warn that demand for weight-loss drug will outstrip supply Around 220,000 patients could be prescribed Mounjaro in the first three years of the drug's availability to NHS patients in England, the National Institute for Health and Care Excellence has estimated.…
NICE rejects Alzheimer’s disease drugs for third time The National Institute for Health and Clinical Excellence said the benefits of donanemab and lecanemab in the treatment of Alzheimer's disease are too small to justify their high costs to the NHS.…
NICE recommends ‘breakthrough’ therapy for blood cancer Belantamab mafodotin combination therapy is a second-line treatment option for multiple myeloma that could benefit around 1,500 people.…
NICE recommends mirikizumab as a treatment option for Crohn’s disease Mirikizumab (Omvoh; Eli Lilly), which is already licensed to treat ulcerative colitis but at a lower dose, is now recommended for the treatment of moderately to severely active Crohn's disease.…
Chronic heart failure deaths could fall by 3,000 per year following updated guidance, says NICE The National Institute for Health and Care Excellence said that drugs are being introduced earlier in patient treatment for chronic heart failure, which has been reflected in its draft guidance.…
Why I set up a pharmacist-led one-stop diabetes clinic in my GP practice How the introduction of a pharmacist-led diabetes clinic has helped to free up GP time and reduce overall hospital admissions, while educating patients on essential care processes.…
NHS England looks to tender contract for behavioural support for patients prescribed tirzepatide in primary care The NHS England document said that patients prescribed tirzepatide in primary care settings will receive “high-quality behavioural wrap-around care” as well as clinical support.…
NICE to work with NHS Race and Health Observatory to de-bias clinical guidance The two-year partnership will examine clinical guidance across maternal and neonatal health, mental health, genomics, sickle cell and hypertension.…
